The field of biosensing is in constant evolution, propelled by the need for sensitive, reliable platforms that provide consistent results, especially in the drug development industry, where small molecule characterization is of uttermost relevance. Kinetic characterization of small biochemicals is particularly challenging, and has required sensor developers to find solutions to compensate for the lack of sensitivity of their instruments. In this regard, surface chemistry plays a crucial role. The ligands need to be efficiently immobilized on the sensor surface, and probe distribution, maintenance of their native structure and efficient diffusion of the analyte to the surface need to be optimized. In order to enhance the signal generated by ...
Biologics are pharmaceutical drug products whose active drug substance is produced in a living organ...
The diagnostic and pharmaceutical industries rely on tools for characterizing, discovering, and deve...
A key activity in small-molecule drug discovery is the characterization of compound–target interacti...
The field of biosensing is in constant evolution, propelled by the need for sensitive, reliable plat...
The influence of mass transport on ligand binding to receptor immobilized in a polymer matrix, as de...
AbstractMany techniques rely on the binding activity of surface-immobilized proteins, including anti...
The immobilisation of biological recognition elements onto a sensor chip surface is a crucial step f...
Nanoparticles are ubiquitously used for signal enhancement in (bio)sensors, but their true possible ...
An affinity biosensor interface of a biosensor is the interface between the sample and the transduce...
149 p.Thesis (Ph.D.)--University of Illinois at Urbana-Champaign, 1998.The specific recognition betw...
The immobilisation of biological recognition elements onto a sensor chip surface is a crucial step ...
The most successful binding kinetics analysis systems at this moment include surface plasmon resonan...
This work aims to find the key factor determining the detection limit for an indirect competitive in...
Surface plasmon resonance biosensors depend on modified gold surfaces to allow immobilization of pro...
Abstract For detection of low concentrations of analytes in complex biological matrices using optica...
Biologics are pharmaceutical drug products whose active drug substance is produced in a living organ...
The diagnostic and pharmaceutical industries rely on tools for characterizing, discovering, and deve...
A key activity in small-molecule drug discovery is the characterization of compound–target interacti...
The field of biosensing is in constant evolution, propelled by the need for sensitive, reliable plat...
The influence of mass transport on ligand binding to receptor immobilized in a polymer matrix, as de...
AbstractMany techniques rely on the binding activity of surface-immobilized proteins, including anti...
The immobilisation of biological recognition elements onto a sensor chip surface is a crucial step f...
Nanoparticles are ubiquitously used for signal enhancement in (bio)sensors, but their true possible ...
An affinity biosensor interface of a biosensor is the interface between the sample and the transduce...
149 p.Thesis (Ph.D.)--University of Illinois at Urbana-Champaign, 1998.The specific recognition betw...
The immobilisation of biological recognition elements onto a sensor chip surface is a crucial step ...
The most successful binding kinetics analysis systems at this moment include surface plasmon resonan...
This work aims to find the key factor determining the detection limit for an indirect competitive in...
Surface plasmon resonance biosensors depend on modified gold surfaces to allow immobilization of pro...
Abstract For detection of low concentrations of analytes in complex biological matrices using optica...
Biologics are pharmaceutical drug products whose active drug substance is produced in a living organ...
The diagnostic and pharmaceutical industries rely on tools for characterizing, discovering, and deve...
A key activity in small-molecule drug discovery is the characterization of compound–target interacti...